Kevin Weil, the former OpenAI executive who led the ChatGPT maker’s AI-for-science efforts, is launching a new startup aimed at using artificial intelligence to speed up a key step of drug development.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in